This year’s JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in New York City.

President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to higher prices for popular weight-loss drugs Ozempic and Wegovy as well as Lego toys, according to a report.

President-elect Donald Trump's viral photo with a Diet Coke bottle highlights its popularity for weight loss. However, this sugar-free drink has poten

Although ending the program won’t be easy since it requires authorization from Congress, recent moves by President-elect Donald Trump’s allies ... so making weight loss drugs more affordable ...

President-elect Donald Trump faces deep skepticism that his administration's policies will make health care more affordable, a new Gallup poll says.

President-elect Donald Trump 's threat to "tariff Denmark at a very high level" if it refuses to give up Greenland could affect weight loss medications like Ozempic, Lego bricks and hearing aids, The New York Times reports.

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.

Although ending the program won’t be easy since it requires authorization from Congress, recent moves by President-elect Donald Trump’s allies may not bode well for its future, said Juliette Cubanski, deputy director of the Medicare policy program at ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 weight-loss drugs — but says subjecting Wegovy to price controls is a bad move.

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.